Perspective Therapeutics, Inc. — Director's Dealing 2011

Nov 22, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2011-11-17

Reporting Person: Babcock Dwight William (Director, CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-11-17	Common Stock	P	2500	$0.77	Acquired	130661	Direct
2011-11-18	Common Stock	P	500	$0.83	Acquired	131161	Direct
2011-11-21	Common Stock	P	400	$0.84	Acquired	131561	Direct
2011-11-21	Common Stock	P	1100	$0.8499	Acquired	132661	Direct
2011-11-21	Common Stock	P	100	$0.85	Acquired	132761	Direct